Products

Compliance Commitment

Integrity Commitment and Compliance Program

Code of Business Ethics

Integrity Commitment Pledge

Kit Description

Photo Guide

Schematic

FAQ

Back to Product List

Catalog #	Kit Name
IF0200G	Q Fever IFA IgG

	Indirect immunofluorescent antibody (IFA) test for the detection and semi-quantitation of human serum IgG antibodies to Coxiella burnetii, the etiologic agent of Q fever. Each kit contains ten 8-well slides with individual spots of C. burnetii phase I and C. burnetii phase II in each well, IgG sample diluent, IgG conjugate, and positive and negative controls.

	Package Inserts

Q Fever (IF0200G and IF0200M)

Slide 1	Slide 2
Negative	Positive
	Phase 1	Phase 2

Q Fever IFA Slide Schematic

Q Fever as Viewed through Microscope

Frequently Asked Questions (FAQ)

Q: How are the antigens arranged on the slide?

A: Please click on the slide schematic for this information. There is an appropriate schematic for each slide type with multiple antigens.

Q: Why are both phases of Coxiella burnetii used in Q Fever testing?

A: The two phases are used to aid in the differentiation of chronic and acute infections.

Q: Why is the positive control for this IFA kit barely positive at the screening dilution?

A: The positive controls are bottled at the screening dilution and can be titered for an endpoint from this dilution. The control should be used in the first well without further dilution.

Back to Product List

First FDA Clearance of a 2009 H1N1 Test Given to Focus Diagnostics

FDA Issues Another Emergency Use Authorization for Commercial H1N1 Flu Test to Quest Diagnostics� Focus Diagnostics

Focus Diagnostics provides the first commercial test for detecting the 2009 H1N1 influenza virus that the FDA has authorized for emergency use.